Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells
暂无分享,去创建一个
Jennifer J. Lhost | D. O’Connor | Wilfried Bardet | W. Hildebrand | R. Wiseman | R. Rudersdorf | B. Burwitz | Shari M. Piaskowski | J. Karl | Lyle T Wallace | A. Detmer | J. Loffredo | J. Greene | D. Cox | Shelby L. O’Connor | B. Bimber | C. Pendley
[1] D. O’Connor,et al. MHC haplotype frequencies in a UK breeding colony of Mauritian cynomolgus macaques mirror those found in a distinct population from the same geographic origin , 2009, Journal of medical primatology.
[2] A. Hughes,et al. Characterization of 47 MHC class I sequences in Filipino cynomolgus macaques , 2009, Immunogenetics.
[3] Donald K Carter,et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis , 2008, The Lancet.
[4] Devan V Mehrotra,et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.
[5] Morten Nielsen,et al. MHC motif viewer , 2008, Immunogenetics.
[6] R. Stebbings,et al. Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). , 2008, The Journal of general virology.
[7] D. O’Connor,et al. Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection. , 2008, Vaccine.
[8] A. Hughes,et al. MHC class I characterization of Indonesian cynomolgus macaques , 2008, Immunogenetics.
[9] R. Sékaly. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? , 2008, The Journal of experimental medicine.
[10] R. Steinbrook. One step forward, two steps back--will there ever be an AIDS vaccine? , 2007, The New England journal of medicine.
[11] M. Carrington,et al. The Major Histocompatibility Complex Class II Alleles Mamu-DRB1*1003 and -DRB1*0306 Are Enriched in a Cohort of Simian Immunodeficiency Virus-Infected Rhesus Macaque Elite Controllers , 2007, Journal of Virology.
[12] M. Carrington,et al. Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication , 2007, Journal of Virology.
[13] A. Tosi,et al. Comparative phylogenetics offer new insights into the biogeographic history of Macaca fascicularis and the origin of the Mauritian macaques. , 2007, Molecular phylogenetics and evolution.
[14] D. Watkins,et al. Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication , 2007, Journal of Virology.
[15] C. Snowdon. The monkey wars , 1996, International Journal of Primatology.
[16] D. Watkins,et al. Beyond Mamu-A*01+ Indian Rhesus Macaques: Continued Discovery of New MHC Class I Molecules that Bind Epitopes from the Simian AIDS Viruses , 2007 .
[17] D. Watkins,et al. The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape , 2006, Journal of Virology.
[18] I. Macchia,et al. Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus. , 2006, The Journal of general virology.
[19] D. O’Connor,et al. Simian Immunodeficiency Virus SIVmac239 Infection of Major Histocompatibility Complex-Identical Cynomolgus Macaques from Mauritius , 2006, Journal of Virology.
[20] M. Carrington,et al. The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication , 2006, Journal of Virology.
[21] Austin L. Hughes,et al. Unusually High Frequency MHC Class I Alleles in Mauritian Origin Cynomolgus Macaques , 2005, The Journal of Immunology.
[22] D. Montefiori,et al. Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239Δ3-Vaccinated Rhesus Macaques , 2005, Journal of Virology.
[23] J. Mascola,et al. Pathogenicity of Simian-Human Immunodeficiency Virus SHIV-89.6P and SIVmac Is Attenuated in Cynomolgus Macaques and Associated with Early T-Lymphocyte Responses , 2005, Journal of Virology.
[24] A. Yamada,et al. Detection of 14 alleles derived from the MHC class I A locus in cynomolgus monkeys , 2004, Immunogenetics.
[25] James Robinson,et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..
[26] Todd M. Allen,et al. Escape in One of Two Cytotoxic T-Lymphocyte Epitopes Bound by a High-Frequency Major Histocompatibility Complex Class I Molecule, Mamu-A*02: a Paradigm for Virus Evolution and Persistence? , 2002, Journal of Virology.
[27] M. Krawczak,et al. MHC Class I Alleles Influence Set-Point Viral Load and Survival Time in Simian Immunodeficiency Virus-Infected Rhesus Monkeys1 , 2002, The Journal of Immunology.
[28] J. Heeney,et al. Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection , 2001, Journal of medical primatology.
[29] Todd M. Allen,et al. CD8+ Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing , 2001, Journal of Virology.
[30] W. Hildebrand,et al. C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells. , 2000, Human immunology.
[31] John Sidney,et al. Definition of the Mamu A*01 Peptide Binding Specificity: Application to the Identification of Wild-Type and Optimized Ligands from Simian Immunodeficiency Virus Regulatory Proteins1 , 2000, The Journal of Immunology.
[32] D. Ho,et al. Enhanced Infectivity of an R5-Tropic Simian/Human Immunodeficiency Virus Carrying Human Immunodeficiency Virus Type 1 Subtype C Envelope after Serial Passages in Pig-Tailed Macaques (Macaca nemestrina) , 2000, Journal of Virology.
[33] A. Perelson,et al. Effects of in Vivo Cd8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine , 2000, The Journal of experimental medicine.
[34] M. Aidoo,et al. Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development. , 2000, Parasitology today.
[35] S O'Brien,et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. , 1999, Journal of immunology.
[36] Todd M. Allen,et al. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. , 1998, Journal of immunology.
[37] H. Clifford Lane,et al. Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques , 1998, Journal of Virology.
[38] Hans-Georg Rammensee,et al. MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.
[39] J. Goedert,et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.
[40] R. Sussman,et al. Mitochondrial DNA of the Mauritian macaques (Macaca fascicularis): an example of the founder effect. , 1995, American journal of physical anthropology.
[41] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[42] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[43] N. Letvin,et al. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys , 1993, Journal of virology.
[44] F. Gao,et al. Human infection by genetically diverse SIVSM-related HIV-2 in West Africa , 1992, Nature.
[45] J. Broderson,et al. Susceptibility of Macaca fascicularis monkeys from Mauritius to different species of Plasmodium. , 1992, The Journal of parasitology.
[46] R. Demars,et al. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.
[47] R. Desrosiers,et al. Comparison of simian immunodeficiency virus isolates , 1988, Nature.
[48] R. Desrosiers,et al. Simian models for AIDS. , 1987, Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc.
[49] H. Orr,et al. Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells , 1986, Molecular and cellular biology.
[50] Gordon A. Harrison,et al. Unity in diversity. The short life of the United Oxford Hospitals , 1979, Medical History.